CFABS

LC-MS/MS Advanced Optimization & Method Development Strategies Course

"Everything you need to know about your LC-MS/MS optimization and method development that may not be written in instrument manuals and books"

May 4-6, 2011, Somerset, New Jersey, USA
September 26-28, 2011, San Francisco, California, USA

About This Course  |   Course Syllabus  |   Course Agenda  |   Instructor Biography  

Registration Fees  |   Online Registration  |   Hotel Accomodation  

 

Course Syllabus

Bring your optimization & method development problems to the course!!!

  • Advanced APCI and APPI Optimization

    • Good reasons for using APCI in fast method development
    • When to use APCI
      • Case Study: Corticosterone and Hydroxyprogesterone optimization
    • Advanced APCI optimization for polar compounds
      • Corona current optimization for polar compounds
      • Case Study: Verapamil and Reserpine optimization
    • APCI limitations
      • Leidenfrost Effect
      • Optimal auxiliary gas optimization for reducing background noise
    • Special and unique solvents for APCI to increase the chemical ionization (CI)
    • APCI vs. ESI
      • Choosing between electrospray and APCI
      • What is the best source for each application?
      • Normal Phase and APCI
        • APCI and ethoxynonafluorobutane (ENBF)
        • Case studies: Normal Phase APCI of steroids, benzodiazepines, central nervous system-active substances, nonsteroidal anti-inflammatory drugs, tricyclic antidepressants, and beta-adrenergic blocking agents.
    • Good reasons for using APPI in fast method development
      • Dopant APPI = Photoionization-induced APCI
      • APPI and Negative Ions
      • Ionization potentials (IP) strategies: solvents with high IP, low IP, medium IP
      • Two commercially available APPI sources: Sciex vs. Syagen - pros/cons
      • Dimers, Methanol, acetonitrile & APPI
    • APCI vs. APPI vs. ESI
      • Polarity (ESI, APCI, APPI, dopant-APPI)
      • Charge competition (ESI, APCI, APPI, dopant-APPI)
      • Ion suppression (ESI, APCI, APPI, dopant-APPI)
      • Flow rates (APCI, APPI, dopant-APPI)
      • Reverse phase vs. normal phase (ESI, APCI, APPI, dopant-APPI)
      • Thermally unstable compound (ESI, APCI, APPI, dopant-APPI)
      • Bioanalytical case study: Testosterone Quantitation and Ritonavir optimization
      • Environmental case study: Carbamate and Phenyl urea
  • Advanced ESI Optimization

    • pH and ESI
    • Specific knowledge in using additives & buffers in ESI(+/-) method development
    • Can you still use Ion Paring Chromatography in ESI?
      • Use of TFA, TCA, HFBA and ion suppression
      • Apffel et al. and the "TFA FIX"
      • Environmental case study: Multiresidue Analysiss of Antibiotics in Food
    • Atypical solvents used in ESI(+) and ESI(-)
      • Use of DMSO in ESI (+): Imipramine & Amitriptyline optimization
      • Use of DMF in ESI (+/-): Hydrophobic peptides and sugars
      • Literature review and unique applications
    • A fast review of the V.I.C. Rule and 5 Gold Roles in advanced ESI optimization
    • Tricks and tips of using post-column additions to enhance sensitivity in ESI
      • Application of post-column addition in ESI
      • Case study: Sensitivity enhancement of ibuprofen by 2-(2-methoxyethoxy)ethanol
  • Advanced Optimization of New API Interfaces

    • Optimization and advantages of new API interfaces in method development
    • Head-to-head performance comparison among:
      • Turbo V (Sciex)
      • IonMax (Thermo)
      • Orthogonal & Jet Stream (Agilent)
      • ZSpray (Waters)
      • Dual off-axis & Heated Auxiliary Vortex Gas (Varian)
    • Flash vaporization in APCI
      • Reduced background noise and memory effect
      • Bioanalytical case study: Ion suppression for beclomethazone
    • Are new ESI sources still concentration dependant?
      • ESI High flow applications
    • New ESI sources ruggedness
    • FAIMS
      • Basic theory and ion mobility
      • Noise reduction
      • Bioanalytical case studies:
        • Phase II metabolites
        • Analysis of Testosterone by LC-FAIMS-MS/MS
  • Sample and Matrix Characterization: The First Step for a Successful Method Development

    • Instrument Setup for Method Development
      • Importance of having a flexible tool for method development
    • Method development steps
    • Gathering information on target analyte and matrix
    • Problem definition and method design
    • Molecular weight considerations and deductions from molecular structure
    • Sample characterization
      • Stability
      • Volatility
      • Polarity
    • Choice of sample preparation according to matrix considerations
      • Main targets of sample pretreatment
    • Main extraction types:
      • Matrix dilution
      • Protein precipitation (PPT)
      • Liquid-liquid extraction (LLE)
      • Solid phase extraction (SPE)
      • On-line extraction and Column Switching Applications
        • Schematic of on-line SPE
        • Turbulent flow: single and dual column mode
      • High throughput applications in sample preparation
  • Developing the Right Chromatography for LC-MS

    • LC parameters
      • HPLC strategies for ESI and APCI
        • Case Study: Lidocaine chromatographic method development
      • Drawbacks of developing LC-MS/MS methods without good chromatographic separations
      • Chromatographic parameters to consider when developing a method in LC-MS
    • Analyte pKa and pH
    • Stationary phases for LC-MS/MS
      • Reverse phase (RP)
      • Polar embedded phase
      • Normal phase (NP)
      • HILIC - Hydrophilic Interaction Liquid Chromatography
        • HILIC benefit in LC-MS/MS
        • Silica
        • Coated silica
        • Amino (NH2) and Amide
        • Selectivity & Stability Comparison: Silica, NH2, Amide
      • UHPLC - Ultra High Performance Liquid Chromatography
        • Compatibility of UHPLC with MS, are we more productive?
        • Efficiency vs. Selectivity: Case study: Positional Isomers of Nicotinamides
      • Fuse-core columns vs. UHPLC vs. Conventional Columns
        • Analytical Case Study: Desmosine and Isodesmosine quantification
        • LC-MS/MS efficiency with Fused-Core columns
        • Matrix interferences on Fuse-core columns
      • Monolithic columns vs. UHPLC
        • Metabolite ID Case Study: Loxapine
        • Separation of Carnitine and Acylcarnitines
    • Column Geometry and size
    • Flow rate and LC Columns
    • Speed & Sensitivity
    • Mobile Phase composition and temperature effect
    • LC column selection
      • What column is best suited for a particular application?
      • Optimal column chemistry for LC-MS/MS applications
      • HPLC method development for screening and qualitative applications
      • HPLC method development for quantitative applications
    • Pre-column vs. filter frit: Dead volume issues in high throughput LC-MS/MS
      • The importance of the Connecting tubes
      • Effect Of Dead Volume On System Performance
      • Particulate material in the sample flow stream
      • Pre-column filter: troubleshooting
    • Pressure vs. flow rate
    • Fast chromatography but at least with K'>2
      • Reduced chromatographic run time in LC-MS/MS
    • Isocratic and gradient LC methods
    • High pH separations and ESI(+)
      • Is it really possible to get positive ions?
      • Columns for high pH mobile phase
      • The post-column addition approach
    • Forensic toxicology case study: Morphine method development
    • Case study: Doping agents in Urine
    • Dwell time & fast chromatography in LC-MS
    • What we have learnt from Acetonitrile (ACN) Worldwide Shortage: LC-MS/MS without ACN
      • Problem identification: ACN is the preferred organic solvent for LC-MS due to its elution strength, low viscosity, low chemical reactivity, and good miscibility with water and mainly lower noise in MS
      • Use of Shorter column with smaller particles
        • Xanthine's case study
      • Use Ultra High Temperature in LC-MS/MS
        • Environmental Case Study: Herbicides
        • Analytical Case Study: Phenoxy Acidis
      • Reduction of the column internal diameter
        • Column performance vs. column diameter
        • Nano-LC and capillary columns
      • Use of other organic modifiers in reversed-phase HPLC
        • Pharmaceutical Case Study: Acetominophen, prednisolone, and corticosterone
      • Chip Technologies
        • LC-Chip-MS/MS –sensitivity & data quality
        • DMPK applications
      • Use of UHPLC
        • Bioanalytical Case Study: Pindolol and Acebutolol in Human Plasma
      • Can you use HILIC without ACN?
        • Other solvents for HILIC: MeOH, EtOH, IPA, THF, Acetone, DMF, MTBE
        • Bioanalytical Case Studies: Muraglitazar in Human Plasma; Cisplatin; Epirubicin
        • Temperature and HILIC: Hydrazine’s case study
  • Main Challenges in LC-MS/MS Method Development and how to overcome them

    • Matrix effects and Ionization effects in the source
      • Matrix Effect, Ion suppression and S/N on Different API sources
        • API3000 vs. Quattro Ultima vs. TSQ 7000
        • API4000 Qtrap vs. Premier vs. TSQ Quantum/Classic
      • General criteria to fight matrix effect
    • Ion suppression
      • Instrument set-up
      • How to minimize ion-suppression
      • Differential suppression
    • Carryover
      • Definition
      • Guidelines
      • Fighting carryover
      • Special washing solutions
      • Accumulation
      • Carryover & contamination
    • Sensitivity Enhancement
      • Improving instrument response and reduce noise and interferences (S/N)
    • How to deal with Isobaric species
      • When the MS/MS selectivity is not enough
      • Chromatographic separation
      • FAIMS
      • High resolution
        • Mass accuracy and resolution
        • Solving problems with high resolution
      • GLP Bioanalytical case study: High resolution in SRM
      • GMP Product development case study: Use of high resolution separations during Sulfonamide method development
    • Interference evaluation
      • Elimination of Interferences in LC-MS/MS
      • GLP Bioanalytical case study: 5-HETE
    • Enantiomeric Separations
      • Separation or analysis of optically active compounds
      • Best available options when confronted with the need for chiral separations in LC-MS/MS
        • Normal phase vs. reverse phase chiral chromatography
      • In vivo conversion R/S: (R,S)-Thalidomide, (R,S)-Oxybutynin, (R,S)-Verapamil & Norverapamil and new NCEs
      • High throughput Chiral Separation Case Study: Metoprolol
  • Qualitative Analysis

    • Overview of drug discovery and development in pharmaceutical industry
      • Professor Mc Lafferty's 4 S
      • Advantages in pharmacokinetic screening
        • Comparison among: HPLV-UV; Radiochemical detection, GC-MS, LC-MS/MS
      • Advantages in pre-clinical
      • Advantages in in vitro drug metabolism
    • Strategies in Identification of Metabolites
      • Case Study: Buspirone metabolites
        • Sciex API4000 Qtrap
        • Thermo LTQ-OrbiTrap
        • UHPLC
      • Data-dependent scan
        • Metabolite ID
        • GMP/CMC – Impurity Detection
        • Identification of Flavonoids
      • Ammonium Bicarbonate for analysis of basic substance in LC-MS/MS
  • Quantitative Analysis

    • Approaches to Quantification
      • Standard curve
        • Limit of Quantification (LLOQ & ULOQ) and other Key Terms
        • Quantitative Relationships in MS Instruments
        • Nature of Regression Errors
      • Standard addition
    • Internal standard
      • Important feature of an internal standard
      • Homologues and Isomers
      • Stable-labeled internal standards: D, 13C and 15N
      • Isotopic purity and problem with deuterated internal standards
        • Ursodiol and Usodiol-d5
        • Oxymorphone and Oxycodone-d3
      • What is the best internal standard?
    • The Validation Process and the Validation Goals
    • Uncertainty in Quantitative Analysis
    • Validation Parameters and Method Validation
      • Accuracy and Precision
      • Analysis of Variance (ANOVA)
      • Assessing Accuracy and Precision
      • Stability Tests
      • Recovery
    • Defining Acceptance Criteria
    • Essential Documentation
    • System Suitability and its Importance
    • The Steps in a Typical MS Quantitative Analysis
    • Routine Sample Analysis
  • Actual Case Studies and Troubleshooting: Pharmaceutical, Environmental & Forensic (recognition, resolution of problems and approaches to systematic troubleshooting)

    • Real world approaches to assessing problems and improving method ruggedness
    • Strategies to reduce or eliminate interferences from metabolite and matrices
      • GLP Bioanalytical case study: Gemcitabine method re-development (HILIC vs. RP Chromatography)
    • GMP Product Development Case Study: Identifying Impurities by LC-MS
      • Sulfachloropyridazine impurities
      • Salbutamol impurities
    • Forensic Toxicology Case Study: Screening of Amphetamines in Urine
      • Sample preparation
      • Confirmation of amphetamines
    • Environmental Analysis Case Study: Pharmaceuticals in Surface Water
      • Sample pre-treatment and enrichment
      • UPLC-MS/MS analysis
    • Optimization by infusion:
      • Erythromycin
      • Vitamin D2
      • Minoxidil
      • Naproxen
      • Progesterone
    • Method development for the identification of polyphenols
    • Best Instrumental conditions for:
      • Acetylmorphine
      • Procainamide
      • Caffeine
      • Propanolol
      • Nortriptyline
      • Oxazepam
      • Ampicillin
      • Clavulanic Acid
      • Ketoralac
      • Triphenyl methane
  • Your Method Development Problem/Challenge

    • Please send to the instructor your "real-world" method development problems in advance so that they could be discussed during the course interactive sessions or if you prefer in 1:1 meetings during the course coffee breaks.
©2008 Canadian LC-MS Group. All Rights Reserved.
+1 (514) 236-4225   |   contact@canadianlcmsgroup.com